GSK Licenses Ontology from BioWisdom, Pathway Data from Ingenuity
GlaxoSmithKline last week signed two licensing deals for research informatics tools.
On Sept. 15, BioWisdom said it had signed a non-exclusive license agreement with GSK to provide elements of its biomedical ontology for diseases, genes and proteins, tissues and cells, drugs, and chemicals. BioWisdom said it would provide GSK with an ontology covering the classification of human proteins that are “of greatest interest for drug discovery.” GSK will have rights to use the ontology across a number of internal applications relevant to R&D and will receive quarterly updates from BioWisdom.
On Sept. 22, Ingenuity Systems said that GSK had licensed part of its Ingenuity Pathways Knowledge Base, a curated database of biological networks created from millions of individually modeled relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.
UB Awarded $2.8M in Bioinformatics Grants from NIH and NSF
The State University of New York at Buffalo last week said it has been awarded two grants totaling $2.8 million to support biomedical informatics research.
One grant, a $1.2 million award from the National Institutes of Health, will establish a Planning Center for Biomedical Computing at the university, where biomedical scientists will work with computational scientists to develop new techniques for storing, managing, analyzing, modeling, and visualizing multi-dimensional data sets that describe complex diseases, the university said.
A second grant of $1.6 million from the National Science Foundation will support the development of methods to integrate genomic and clinical data.